Weiss Multi-Strategy Advisers’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-263,519
Closed -$2.96M 390
2023
Q4
$2.96M Buy
263,519
+108,244
+70% +$1.05M 0.07% 317
2023
Q3
$1.81M Sell
155,275
-89,974
-37% -$1.02M 0.04% 386
2023
Q2
$2.47M Buy
+245,249
New +$2.19M 0.05% 440

Other funds holding ROIV

Weiss Multi-Strategy Advisers's ROIV Position: Q1 2024 in Review

Weiss Multi-Strategy Advisers sold out of Roivant Sciences (ROIV) in Q1 2024, closing a stake of 263,519 shares — an estimated $2.96M sold.

Weiss Multi-Strategy Advisers first reported a position in ROIV in Q2 2023 and held it in 3 quarters. The position peaked at $2.96M in Q4 2023. 259 funds tracked by Wall St. Rank hold ROIV as of Q1 2024.

  • Weiss Multi-Strategy Advisers reported no remaining Roivant Sciences position as of Q1 2024 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 263,519 Roivant Sciences shares in Q1 2024, an estimated $2.96M.
  • Weiss Multi-Strategy Advisers first reported a position in Roivant Sciences in Q2 2023 and held it in 3 quarters.
  • Weiss Multi-Strategy Advisers's Roivant Sciences position peaked at $2.96M in Q4 2023.
  • 259 funds tracked by Wall St. Rank held Roivant Sciences as of Q1 2024.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2024.